CD8A and neoplasm: This clearly illustrated that the anti-tumoral effects of pcTERT-Noxa or pcTERT-Puma may be partly mediated by altering infiltration of CD3+, CD8+and CD45+ T cells triggered by the increased expression of Noxa or Puma in the tumor tissues.